Complex coacervation between oppositely charged proteins and polyelectrolytes has broad relevance, from membraneless organelles to biomedical applications. Unlike well-characterized synthetic polyelectrolytes, protein coacervates pose experimental challenges due to limited quantities, constraints of mild handling, fine-tuning of pH, and ionic strength affecting contributions of charge patches or non-Coulombic binding. To alleviate these constraints, we propose to use a microdialysis chip allowing in situ control of microvolumes. We studied model lysozyme/polyglutamate coacervates. Rapid equilibration with phosphate buffers of varying concentrations showed that (i) fine control of the ionic strength was essential due to the release of counterions affecting the phase diagram above 80 g/L lysozyme, (ii) phase separation was reversible, (iii) chirality of the polyglutamate affects coacervation, and (iv) coacervates can be annealed into homogeneous films allowing FRAP measurements across fluid-like to solid-like transition as betrayed by a marked decrease of polyglutamate diffusivity below a threshold of 60 mM phosphate.
Brassart et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: